Currently, there are no FDA approved medications for treating fragile X syndrome. That may soon change, thanks to a $11.5 million NIH grant awarded to UC Davis Medical Center. The new funding will allow researchers to test a new drug that is designed to improve language learning for children with fragile X syndrome. UC Davis is one of only two medical centers approved for the drug trail in the nation. Since UC Davis Medical Center is home to the renowned MIND Institute, which hosts the Fragile X Research and Treatment Center, it is a logical choice for the treatment study.
Read MoreRecent Posts
0 Comments Click here to read/write comments
Tags: CA, California, Research Funding, Drug Development, research grant, UC Davis - Medical Center, Southwest Region, new research grant, UCD, drug evaluation, BioResearch Product Faire, Bioresearch Grant
Despite recent advances in neuroimaging, the medical community still lacks a comprehensive map of the brain and how it changes with age. Such maps would make it possible for doctors to distinguish between what is normal aging and what is atypical, which would make it possible to link atypical changes to neurological diseases and various mental health issues. Thanks to a $34 million NIH grant, Washington University School of Medicine in St. Louis will lead a project to make such maps of the brain a reality.
Read More
0 Comments Click here to read/write comments
Tags: Washington University St. Louis, WUSTL, Biotechnology Vendor Fair, Research Funding, NIH grant, laboratory equipment sales, research grants
Researchers at Texas Medical Center’s Rice University recently discovered that Huntington’s Disease might be triggered by a repeating nucleotide sequence in the gene for a mutant protein. The research team conducted this study by analyzing proteins that were suspected to misfold and form plaques in the brains of patients with neurological diseases.
Read More
0 Comments Click here to read/write comments
Tags: Texas Medical Center, Texas, Biotech Еvent, tmc, Biotechnology Vendor Fair, Southwest Region, Huntington's Disease
The University of Georgia, Athens has been awarded a four-year $1.3 million research grant from the National Institute of Health to create a method of analyzing the large amount of biological data generated by current biotechnology. The funding will be used to develop better statistical tools for crunching big data numbers in order to clarify the causes of several serious illnesses including cancer and heart disease.
Read More
0 Comments Click here to read/write comments
Tags: University of Georgia Athens, University of Georgia, UGA, Biotechnology Vendor Fair, Research Funding
The National Institute of Aging has awarded a five year, $10.3 million grant to the University of Arizona, Tucson to fund research on why women are more susceptible to developing Alzheimer's Disease than men are. Lead researcher Dr. Roberta Diaz Brinton will be collaborating with other UA investigators, as well as with researchers at the University of Southern California with specialties including; neuroimaging and informatics, pharmacology, gerontology, and neuroradiology.
-MRI-1.png?width=248&name=Cerebral_amyloid_angiopathy_(CAA)-MRI-1.png)
(Image of brain affected byAlzheimer's courtesy of Wikimedia Commons)
Read More
0 Comments Click here to read/write comments
Tags: Bioresearch funding, Biotechnology vendor show, University of Arizona Tucson Research, Alzheimer' Research, University of Arizona Tucson, UA
University of South Florida Nursing’s professor, Maureen Groer, PhD recently received funding to extend her research on preterm infants and the microbiome of their digestive system. This research grant from the National Institute of Health (NIH) is part of a $150 million program called Environmental influences on Child Health Outcomes (ECHO). The focus of ECHO is to allow researchers to study the impact that environmental influences have on children by extending and expanding existing studies on mothers and their children. It will involve 50,000 children the across the United States.
Read More
0 Comments Click here to read/write comments
Tags: new research funding, environmental contaminants, Environment, Florida, Research Funding, Southern Region, new research grant, University of South Florida, USF
UC Davis Medical Center researchers have recently been awarded several grants to investigate promising treatments for Angleman Syndrome. Dr. David Segal, professor in the Department of Biochemistry and Molecular Medicine, has received over $1.2 million from the Foundation for Angelman Syndrome Therapeutics (FAST) to develop a potential treatment. Joe Anderson, PhD, assistant adjunct professor in the Department of Internal Medicine, received $500,000 from the same organization to pursue a different approach to developing a treatment for the genetic disorder. The university also received a $1.1 million grant from the California Institute for Regenerative Medicine (CIRM) in July, which brings the total for Angelman Syndrome grant funding to nearly $3 million. This puts UC Davis at the forefront of research into the disorder.
(Image of UBE3A Protien courtesy of Wikimedia Commons)
0 Comments Click here to read/write comments
Tags: Biotechnology vendor show, Biotechnology Vendor Fair, UC Davis - Medical Center, research grants, UC Davis, Bioresearch Grant, angelman syndrome
Traumatic brain injury, or TBI, is the leading cause of disability among U.S. military personnel and veterans. What’s more, 50% of people with TBI develop spontaneous seizures. If the seizures become recurrent then the condition qualifies as Post-Traumatic Epilepsy, PTE. Now thanks to a 3 year, $750,000 research grant from the Department of Defense and the Army, researchers at Texas A&M will conduct a study on TBI to uncover the molecular and epigenetic mechanism of PTE.
Read More
0 Comments Click here to read/write comments
Tags: Epilepsy, Texas A&M University, Texas, Research Funding, TX, research grant, Southwest Region, new research grant
Researchers at Texas Medical Center’s McGovern School of Medicine piloted a revolutionary way of treating spina bifida patients in utero. The new method utilizes a patch made from human umbilical cord and the regenerative tissue does not cause scarring, which often leads to complications. Recent clinical trials preformed at TMC’s Fetal Center at Children’s Memorial Hermann Hospital showed improved outcomes for babies inflicted with the birth defect.
Read More
0 Comments Click here to read/write comments
Tags: biomedical research, Texas Medical Center, tmc, Biotechnology Vendor Fair, laboratory equipment sales, spinal cord injury, McGovern Medical School, Huston, Texas, spina bifida
UC Davis Professor Kit Lam has been awarded two separate federal grants to further his cancer research. The first grant is from the National Institute of Biomedical Imaging and Bioengineering. This 4-year, $2 million grant will fund research on the use of targeted nanotheraputics against oral cancer. The second grant is from the National Cancer Institute. This 3-year, $1.2 million research grant will be used to explore new technology for functional imaging in living cells.
Read More
0 Comments Click here to read/write comments
Tags: cancer research, California, Cancer, UCDMC, Research Funding, UC Davis - Medical Center, Southwest Region, research grants, UC Davis, UCD, cancer research grant